Physician profile
George John
NPI 1124027958
$1,596.04
in general payments reported to CMS, 2019-2025
14 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2021: $104 · 2022: $236 · 2023: $28.75 · 2024: $385 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $225.72 | 2022-2024 | |
| Janssen Biotech, INC. | $143.83 | 2023-2025 | Tremfya, Simponi, Simponi Aria |
| Novo Nordisk INC | $138.00 | 2025 | Wegovy, Ozempic, Rybelsus |
| Phathom Pharmaceuticals, INC. | $134.19 | 2024 | Voquezna |
| Abbvie INC. | $125.40 | 2024 | |
| Genzyme Corporation | $123.97 | 2022 | |
| Gilead Sciences, INC. | $121.84 | 2025 | Livdelzi |
| Amgen INC. | $119.31 | 2025 | Uplizna |
| Pfizer INC. | $110.97 | 2019 | |
| Janssen Scientific Affairs, LLC | $110.33 | 2019 | |
| Evoke Pharma, INC. | $103.76 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.58 | 2019 | |
| Kestra Medical Technology Services, INC. | $29.35 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals Lp | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.